New Frontier in Cancer Immunotherapy: Sexual Dimorphism of Immune Response

Keyphrases

• In Cancer 100%
• Immune Response 100%
• Sex Differences 100%
• Metaanalysis 100%
• Sexual Dimorphism 100%
• Metabolomics 100%
• Cancer Immunotherapy 100%
• New Frontiers 100%
• Immunotherapy Efficacy 100%
• Hazard Ratio 50%
• Immunological Response 50%
• Tryptophan 50%
• Sex-specific 50%
• Treatment Response 50%
• Cancer Progression 50%
• Immunotherapeutic Strategy 50%
• Immune Checkpoint Blockade 50%
• Response Rate 50%
• Clinical Investigation 50%
• Immune Function 50%
• Metabolic 50%
• Metabolic Profiling 50%
• Microbiome 50%
• Cancer Therapeutics 50%
• Ongoing Clinical Trials 50%
• Mechanistic Evidence 50%
• Metabolic Pathway 50%
• Short-chain Fatty Acids 50%
• Immune Checkpoint Inhibitors 50%
• Patient Stratification 50%
• Systemic Treatment 50%
• Lipidomics 50%
• Precision Oncology 50%
• Indoleamine 2,3-dioxygenase 1 (IDO1) 50%
• Analytic Data 50%
• Neoadjuvant Setting 50%
• Biochemical Pathways 50%
• Therapeutic Outcome 50%
• Kynurenine 50%
• Overall Survival Benefit 50%
• Metabolic Biomarkers 50%
• Sex-specific Differences 50%
• Systemic Immunity 50%
• Major Pathologic Response 50%
• Hormone Modulation 50%

Biochemistry, Genetics and Molecular Biology

• Immune Response 100%
• Metabolomics 100%
• Cancer Immunotherapy 100%
• Sex Differences 100%
• Clinical Trial 25%
• Metabolite 25%
• Overall Survival 25%
• Immune Checkpoints 25%
• Indoleamine 2,3-dioxygenase 25%
• Microbiome 25%
• Lipidomics 25%
• Short-Chain Fatty Acid 25%
• Tryptophan 25%
• Kynurenine 25%
• Immune Checkpoint Inhibitor 25%